Real world data and FDA: Drugmakers seek more clarity on registry guidance

As the FDA crafts a new series of guidance documents on how biopharma companies can use real-world data, including patient registries, to help supplement their applications, pharma companies and industry group PhRMA are calling for more details and more consistency from the agency.

The push from...

Click to view original post